About PreventionGenetics
PreventionGenetics is a Healthcare company based in Marshfield (United States) founded in 2004 by James Weber, and was acquired by Exact Sciences in January 2022. Clinical gene sequencing services and duplication tests are provided. The company has 205 employees. Its chief executive, as recorded, is James Weber. Its website preventiongenetics.com draws about 24 thousand monthly visits. PreventionGenetics offers products and services including PGnome, PGxome, PGmax, and Custom Panels. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity is PREVENTIONGENETICS, LLC. Its competitors include Omniome, Tessera Therapeutics and Phase Genomics; 3 of its 3 listed competitors have raised funding.
Company details
PreventionGenetics was founded in 2004 in Marshfield, United States. Sequencing services and duplication tests for clinical genes are offered within the genetic diagnostics sector. Whole-exome sequencing tests are performed using the PGxome platform. DNA banking is facilitated through the PGDNA bank. Additional tests, including KATNB1 Gene Sequencing and the Parkinson Disease and Parkinsonism Sequencing Panel, are available to support clinical applications.
- Headquarters Marshfield, United States
- Employees 205
- Founders James Weber
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website preventiongenetics.com
- Social LinkedIn X Facebook Instagram
- Acquired by Exact Sciences (Jan 2022)
- Legal Name Preventiongenetics, Llc
- Investors
- Employee Count205
- Acquired byExact Sciences
(Jan 2022)
Products & Services of PreventionGenetics
PreventionGenetics offers a comprehensive portfolio of products and services, including PGnome, PGxome, PGmax, and Custom Panels.
Comprehensive DNA testing for clinical genetic diagnosis.
Advanced genetic testing for identifying variants.
Tailored DNA tests for specific genetic disorders.
Specialized panels for various disease categories.
Investors in PreventionGenetics
PreventionGenetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Non-invasive molecular diagnostic tests for cancer detection are provided. | 1995 | exactsciences.com | Madison, United States |
Investor details for PreventionGenetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PreventionGenetics
637 people are tracked at PreventionGenetics (189 in leadership, 9 in board & advisors, 439 in team); the tracked headcount is 205.
| Name | Role | Group |
|---|---|---|
James Weber | Founder & CEO | Leadership |
Michelle Beidelschies | Medical Affairs Director, Multi-cancer Early Detection - Thrive | Leadership |
Isaac Kinde | VP Technology Assessment | Leadership |
Anurag Gupta | Director, APAC - Indirect Markets | Leadership |
Jessica Angelos Castro | Emerging Capabilities, Strategic Innovation, And Partnerships- Growth Initiatives, Senior Director | Leadership |
Kevin Conroy | Chairman & CEO | Leadership |
Kristin Lamont | Director Medical Education & Information | Leadership |
Alex S. | Associate Director, International Accounting | Leadership |
Mark Hollenbeck | Associate Director, Enterprise Data | Leadership |
Patrick Tibbetts | Associate Director Of Data Engineering | Leadership |
Amir Khan | Chief Information Security Officer | Leadership |
Raj Pudipeddi | Chief Growth Officer | Leadership |
Sean Rollins | Director, IT Business Relationship Management - R&d And Corporate Strategy | Leadership |
Whitney Rusch | Director, Enterprise Platforms | Leadership |
Roman Mey | Director – Global IT Support Center Services | Leadership |
Courtney Cerdena | Sr. Director Of IT Solution Delivery | Leadership |
Matt Ford | Senior Director, Commercial Performance And Training | Leadership |
Rebeca Monsma | Principal Human Resources Business Partner | Leadership |
Bradley Arrick | Director, Oncology Medical Development | Leadership |
Eric Gagne | Lab Director | Leadership |
617 more people are available in the full profile.
Complete people profiles for PreventionGenetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PreventionGenetics
2 dated milestones of PreventionGenetics across 18 years, from founding to its latest funding, stage changes and deals.
- Founded PreventionGenetics is founded.
- Exit Acquired by Exact Sciences.
Competitors of PreventionGenetics
PreventionGenetics has 3 listed competitors in our database, 3 of them funded. They include Omniome, Tessera Therapeutics and Phase Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| tesseratherapeutics.com | 2017 | Cambridge, United States | $610M | 149 | New genome engineering technology is provided for treating multiple diseases. | |
| phasegenomics.com | 2015 | Seattle, United States | $5.75M | 19 | Laboratory and computational services for DNA proximity analysis are provided. |
Detailed competitors of PreventionGenetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PreventionGenetics
The website of PreventionGenetics (preventiongenetics.com) receives about 24.4K visits a month.
- Monthly visits24.4K
▼ 17% vs previous month
Websites whose visitors overlap most with PreventionGenetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| invitae.com | 100% | 439.4K | #95,124 | View details | |
| fulgentgenetics.com | 80% | 37.8K | #812,411 | View details | |
| ambrygen.com | 78% | 189.2K | #206,714 | View details | |
| pkdcure.org | 76% | #884,304 | View details | ||
| blueprintgenetics.com | 75% | 40.7K | #816,872 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for PreventionGenetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as PreventionGenetics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Preventiongenetics
Complete news archive for PreventionGenetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PreventionGenetics
PreventionGenetics was founded in 2004.
PreventionGenetics is headquartered in Marshfield, United States. It is registered at Marshfield, Wisconsin, United States.
James Weber is the CEO of PreventionGenetics, as recorded in our data. They have also founded this company.
PreventionGenetics has 205 employees.
PreventionGenetics was founded in 2004 in Marshfield, United States. Sequencing services and duplication tests for clinical genes are offered within the genetic diagnostics sector. Whole-exome sequencing tests are performed using the PGxome platform. DNA banking is facilitated through the PGDNA bank. Additional tests, including KATNB1 Gene Sequencing and the Parkinson Disease and Parkinsonism Sequencing Panel, are available to support clinical applications.
PreventionGenetics's top competitors include Tessera Therapeutics, Phase Genomics and Omniome.
PreventionGenetics offers PGnome, PGxome, PGmax, and Custom Panels.
PreventionGenetics has 1 investor. Key investors include Exact Sciences.
PreventionGenetics operates through Preventiongenetics, Llc.
Yes. PreventionGenetics was acquired by Exact Sciences in January 2022.